U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478575) titled 'Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure' on March 12.
Brief Summary: This retrospective cohort study investigates the effects of SGLT2 inhibitor therapy on erythropoiesis and its association with cardiac and renal outcomes in patients with chronic heart failure. The study will compare hematological parameters, echocardiographic measures, and clinical outcomes between patients who initiated SGLT2 inhibitor therapy and a matched control group receiving guideline-directed medical therapy alone over a 12-month follow-up period.
Study Start Date: Jan. 01, 2019
Study Type: OBSERVATIONAL
Condition:
Heart Failure...